SUBCUTANEOUS FAT
Clinical trials for SUBCUTANEOUS FAT explained in plain language.
Never miss a new study
Get alerted when new SUBCUTANEOUS FAT trials appear
Sign up with your email to follow new studies for SUBCUTANEOUS FAT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Belly fat melting shot? phase 3 trial begins.
Disease control Not yet recruitingThis Phase 3 trial tests whether an injection called CBL-514 can safely reduce abdominal fat. 300 adults with moderate to severe belly fat will receive either the drug or a placebo. The study measures fat loss by MRI and patient ratings over time.
Matched conditions: SUBCUTANEOUS FAT
Phase: PHASE3 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New injection melts belly fat in clinical trial
Symptom relief Not yet recruitingThis study tests an injection called CBL-514 to see if it can safely reduce belly fat. About 250 adults with extra abdominal fat will receive either the injection or a placebo. The goal is to measure fat loss using MRI and doctor ratings.
Matched conditions: SUBCUTANEOUS FAT
Phase: PHASE2 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New shot aims to melt belly fat without surgery
Symptom relief Not yet recruitingThis phase 3 trial tests an injection called CBL-514 to see if it can safely reduce belly fat. About 320 adults with moderate to severe abdominal fat will receive either the drug or a placebo. The main goal is to see if more people in the drug group report a meaningful fat reduct…
Matched conditions: SUBCUTANEOUS FAT
Phase: PHASE3 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC